| Paulina Maida, MD | |
|
150 Frankfort Rd Ste 101, Shelbyville, KY 40065-7401 | |
| (502) 647-5468 | |
| Not Available |
| Full Name | Paulina Maida |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 150 Frankfort Rd Ste 101, Shelbyville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699139949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 56796 (Kentucky) | Primary |
| 208000000X | Pediatrics | 25MA10615100 (New Jersey) | Secondary |
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
The United States Patent and Trademark Office today awarded St. Jude Children's Research Hospital U.S. patent number 8,399,645 for St. Jude's invention of compositions for genetically modifying human immune cells so they can destroy some of the most common forms of cancer in children and adults.
A team of researchers at University College London, UK, recently explored how the COVID-19 pandemic has affected the mental health of older adults across Britain.
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
Eating less late at night may help curb the concentration and alertness deficits that accompany sleep deprivation, according to results of a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented at SLEEP 2015, the 29th annual meeting of the Associated Professional Sleep Societies LLC.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT), the world's leading developer of medical devices, announced today the presentation of new pre-clinical research findings from their Huntington's disease program at the 2009 World Congress on Huntington's Disease held September 12-15, 2009 in Vancouver, British Columbia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paulina Maida, MD Po Box 776879, Chicago, IL 60677-6879 Ph: (502) 588-9490 | Paulina Maida, MD 150 Frankfort Rd Ste 101, Shelbyville, KY 40065-7401 Ph: (502) 647-5468 |
News Archive
The United States Patent and Trademark Office today awarded St. Jude Children's Research Hospital U.S. patent number 8,399,645 for St. Jude's invention of compositions for genetically modifying human immune cells so they can destroy some of the most common forms of cancer in children and adults.
A team of researchers at University College London, UK, recently explored how the COVID-19 pandemic has affected the mental health of older adults across Britain.
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
Eating less late at night may help curb the concentration and alertness deficits that accompany sleep deprivation, according to results of a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented at SLEEP 2015, the 29th annual meeting of the Associated Professional Sleep Societies LLC.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT), the world's leading developer of medical devices, announced today the presentation of new pre-clinical research findings from their Huntington's disease program at the 2009 World Congress on Huntington's Disease held September 12-15, 2009 in Vancouver, British Columbia.
› Verified 5 days ago
Kelsea Lea Creason, PA Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 231 Midland Park, Shelbyville, KY 40065 Phone: 502-633-6411 | |
Arlyn E. Lua-canby, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Frankfort Rd, Suite 101, Shelbyville, KY 40065 Phone: 502-647-5468 Fax: 502-647-7134 | |
Edward L Sames, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 515 Hospital Dr, Suite 1, Shelbyville, KY 40065 Phone: 502-633-3525 Fax: 502-633-8075 | |
Laura P White, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 140 Stonecrest Rd, Ste 101, Shelbyville, KY 40065 Phone: 502-633-6411 Fax: 502-633-6657 | |
Dr. Jessica N B Easterling, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Frankfort Rd Ste 101, Shelbyville, KY 40065 Phone: 502-647-5468 Fax: 502-732-7136 | |
Sarah Hawkins, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Frankfort Rd Ste 101, Shelbyville, KY 40065 Phone: 502-647-5468 Fax: 502-647-7134 |